What is the current treatment of PTLD after liver transplantation?

被引：11

作者：

Dufour, JF

Fey, MF

机构：

[1] Univ Bern, Dept Clin Pharmacol, CH-3010 Bern, Switzerland

[2] Univ Bern, Inselspital, Dept Med Oncol, CH-3010 Bern, Switzerland

来源：

JOURNAL OF HEPATOLOGY | 2006年 / 44卷 / 01期

关键词：

D O I：

10.1016/j.jhep.2005.10.009

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：23 / 26

页数：4

共 34 条

[1] Biliary stricture secondary to donor B-cell lymphoma after orthotopic liver transplantation [J].

Baron, PW ;

Heneghan, MA ;

Suhocki, PV ;

Nuckols, JD ;

Tuttle-Newhall, JE ;

Howell, DN ;

Clavien, PA .

LIVER TRANSPLANTATION, 2001, 7 (01) :62-67

[2] Asymptomatic small bowel intussusception associated with post-transplant lymphoproliferative disease [J].

Barshes, NR ;

Lee, TC ;

Karpen, SJ ;

Bristow, LJ ;

Quiros-Tejeira, RE ;

Goss, JA .

PEDIATRIC TRANSPLANTATION, 2004, 8 (02) :196-197

[3] Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients [J].

Berney, T ;

Delis, S ;

Kato, T ;

Nishida, S ;

Mittal, NK ;

Madariaga, J ;

Levi, D ;

Nery, NR ;

Cirocco, RE ;

Gelman, B ;

Ruiz, P ;

Tzakis, AG .

TRANSPLANTATION, 2002, 74 (07) :1000-1006

[4] Epstein-Barr virus-negative precursor B cell lymphoblastic lymphoma after liver transplantation: A unique form of posttransplant lymphoproliferative disease [J].

Borges, E ;

Ferry, JA ;

Friedmann, AM .

TRANSPLANTATION, 2002, 73 (04) :541-543

[5] Primary central nervous system posttransplant lymphoproliferative disorders [J].

Castellano-Sanchez, AA ;

Li, SY ;

Qian, J ;

Lagoo, A ;

Weir, E ;

Brat, DJ .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (02) :246-253

[6] Infusion of autologous Epstein-Barr virus (EBV) -: specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication [J].

Comoli, P ;

Labirio, M ;

Basso, S ;

Baldanti, F ;

Grossi, P ;

Furione, M ;

Viganò, M ;

Fiocchi, R ;

Rossi, G ;

Ginevri, F ;

Gridelli, B ;

Moretta, A ;

Montagna, D ;

Locatelli, F ;

Gerna, G ;

Comoli, P .

BLOOD, 2002, 99 (07) :2592-2598

[7] Interferon-α treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants [J].

Davis, CL ;

Wood, BL ;

Sabath, DE ;

Joseph, JS ;

Stehman-Breen, C ;

Broudy, VC .

TRANSPLANTATION, 1998, 66 (12) :1770-1779

[8]

Dotti G, 2001, HAEMATOLOGICA, V86, P618

[9] Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder [J].

Ganne, V ;

Siddiqi, N ;

Kamaplath, B ;

Chang, CC ;

Cohen, EP ;

Bresnahan, BA ;

Hariharan, S .

CLINICAL TRANSPLANTATION, 2003, 17 (05) :417-422

[10] Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients [J].

Ganschow, R ;

Schulz, T ;

Meyer, S ;

Broering, TC ;

Burdelski, M .

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 38 (02) :198-203

← 1 2 3 4 →